is zepbound a glp 1 agonist You might know them as Ozempic, Wegovy, Mounjaro, and Zepbound. GLP-1 receptor agonists are best known for managing diabetes and promoting weight loss, but researchers are discovering wide spectrum of effective Zepbound vs Saxenda: Which Is

ISSN 0367-8377

Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol

Others may argue that for people who have a large percentage of weight to lose and struggle getting started with a more foundational approach to weight loss, drugs like Wegovy can give them a jump start or help get their foot in the door on healthier habits by helping them control their appetite in the beginning

GLP-1 was shown to manage blood sugar levels by improving insulin function, lowering glucagon levels, and delaying gastric emptying

With these actions come reactions, or side effects: Hypoglycemia can occur if too much sugar leaves the bloodstream and glucagon action is blocked